Canopy Growth’s Spectrum Cannabis enters the UK and Poland

Grow Opportunity Staff
January 23, 2019
By Grow Opportunity Staff
Medical cannabis company Spectrum Cannabis has expanded its cannabis production and distribution network into the United Kingdom and Poland.

Spectrum Biomedical UK is the company’s U.K., venture which is providing access to cannabis-based medicinal products to U.K., patients with severe unmet clinical need, a release stated.

"There is significant real-world and clinical evidence supporting the safety and effectiveness of cannabis-based medicinal products,” stated Dr. Mark Ware, chief medical officer of parent company Canopy Growth. “However, due to the current regulations and lack of education about medicinal cannabis among clinicians in the U.K., there remain considerable obstacles to patient access.”

Under the British government's new classification, which took effect Nov. 1, specialist doctors in the U.K., can prescribe cannabis-based medicines to patients managing a wide range of symptoms – from chronic pain, chemotherapy-induced nausea and vomiting, to muscle spasticity for those with multiple sclerosis, the release stated.

In Poland, Spectrum Cannabis Polska successfully completed its first import of medical cannabis after completing a rigorous regulatory approval process to have the product assessed and approved for sale, the company stated.

In last week's import, Spectrum Cannabis Polska received its high-THC whole flower product, Red No. 2. "This shipment is an important first step in a new European market towards building our pan-European operations," said Dr. Pierre Debs, managing director of Canopy Growth Europe. "We continue to follow our overall plan of self-sufficiency in Europe to be able to best provide individuals with high-quality medical cannabis."

Spectrum Cannabis Polska is a new entity and the fifth of its kind for the company in European markets. According to the Polish Pharmaceutical Chamber, which represents about 15,000 pharmacies in Poland, it is estimated that up to 300,000 patients could qualify for medical cannabis treatment.

Grow Opportunity
GET CONNECTED

Stay in-the-know on innovative ways to manage your cannabis business, and grow better. Subscribe to our weekly eNewsletter and be the first to hear what’s new in this fast growing industry.

Add comment


Security code
Refresh

Subscription Centre

 
New Subscription
 
Already a Subscriber
 
Customer Service
 
View Digital Magazine Renew

Most Popular

Latest Events

MJBizConNEXT
Wed Jun 12, 2019
Grower Day
Tue Jun 18, 2019

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.